NCT04606862 is a NA clinical trial of Morley Medical Sepsis Software Device in Sepsis, sponsored by Morley Medical.

Who is sponsoring NCT04606862?

NCT04606862 is sponsored by Morley Medical.

What drugs are being tested in NCT04606862?

Interventions in NCT04606862: Morley Medical Sepsis Software Device.

Is NCT04606862 still recruiting?

NCT04606862 is currently status unknown. Last updated 28 October 2020.

Last reviewed 2020-10-28 · How we verify

NCT04606862

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A Clinical Trial to Evaluate the Efficacy of the Morley Medical Sepsis (MMS) Software Device in Predicting Sepsis in Adult Patients Using Artificial Intelligence (AI) Machine Learning Algorithms

Status unknown NA Last updated 28 October 2020

What this trial tests

NA trial testing Morley Medical Sepsis Software Device in Sepsis in 10,000 participants. Status unknown.

Timeline

31 October 2020

Primary endpoint
31 December 2020

31 December 2020

Quick facts

Lead sponsor	Morley Medical
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	none
Primary purpose	diagnostic
Enrollment	10,000
Start date	31 October 2020
Primary completion	31 December 2020
Estimated completion	31 December 2020

Drugs / interventions tested

Morley Medical Sepsis Software Device

Conditions studied

Sepsis — all drugs for Sepsis →

Sponsor

Morley Medical

Who can join

18 and older, any sex, with Sepsis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a pivotal medical device clinical trial evaluating the clinical outcomes in hospitalized patients monitored with the Morley Medical Sepsis Software Device. The device uses unique AI machine learning algorithms to analyze patient data in real time and generate clinical decision support sepsis risk predictions for clinicians.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Sepsis

Currently open trials in the same condition.

NCT07507877 — Infraclavicular Axillary Vein Collapsibility Index as a Predictor of Fluid Responsiveness · recruiting
NCT07154615 — Assessing Immune Dysfunction in Sepsis · recruiting
NCT07419802 — OxiCLEAR (Oxiris Cytokines and Endotoxin Adsorption Rate) Study · recruiting
NCT07351344 — African Survey on Sepsis Knowledge (ASK) · recruiting
NCT07448805 — Accuracy and Safety of the Syai Tag System for Continuous Glucose Monitoring in Intensive Internal Care Unit · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04606862 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Morley Medical
Last refreshed: 28 October 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04606862.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing